Title
Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru
Date Issued
01 August 2010
Access level
metadata only access
Resource Type
journal article
Abstract
Human T-lymphotropic virus 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) affects approximately 5% of HTLV-1-infected individuals. It is poorly understood why only some infected subjects develop this disease, but host genetic factors may determine susceptibility. The innate immune system may influence disease outcome in HTLV-1-infected individuals because of its role in early immune responses to viral infections. Variation in genes encoding killer cell immunoglobulin-like receptors (KIR) and their human leukocyte antigen (HLA) molecule ligands may affect the risk of HAM/TSP. We performed a two-stage case-control study to examine the distribution of KIR genes and HLA-Cw groups in Peruvian HTLV-1-infected HAM/TSP individuals and asymptomatic carriers. We also tested for epistatic effects between specific KIR genes and HLA-Cw groups. In the first stage, we found several trends toward association with HAM/TSP or proviral load (PVL). However, these results were not replicated in the second stage. In conclusion, this is the first report on KIR gene frequencies in the Peruvian population and may be of significance in hematopoietic stem-cell transplants. Our study did not reveal significant associations between KIR genes and HLA-Cw groups and HAM/TSP or PVL. However, because our study was powered to detect only larger effects, additional studies using larger cohorts are needed. © 2010 American Society for Histocompatibility and Immunogenetics.
Start page
804
End page
808
Volume
71
Issue
8
Language
English
OCDE Knowledge area
Epidemiología Inmunología
Scopus EID
2-s2.0-77954757014
PubMed ID
Source
Human Immunology
ISSN of the container
01988859
Sponsor(s)
We thank the patients and the staff of the HTLV-1 study group of the Institute of Tropical Medicine, Alexander von Humboldt–Universidad Peruana Cayetano, Heredia. This study was supported by the Directorate-General for Development Cooperation of the Belgian Government through the framework agreement with the Institute of Tropical Medicine of Antwerp and through the Flemish Interuniversity Council (VLIR).
Sources of information: Directorio de Producción Científica Scopus